The DOI matches its Crossref record; 9 of the 9 references it cites were found in a registry or an index.
Antimicrobial-Resistant Pathogens Associated with Healthcare-Associated Infections Summary of Data Reported to the National Healthcare Safety Network at the Centers for Disease Control and Prevention, 2009–2010
Abstract
Objective.: To describe antimicrobial resistance patterns for healthcare-associated infections (HAIs) reported to the National Healthcare Safety Network (NHSN) during 2009-2010. Methods.: Central line-associated bloodstream infections, catheter-associated urinary tract infections, ventilator-associated pneumonia, and surgical site infections were included. Pooled mean proportions of isolates interpreted as resistant (or, in some cases, nonsusceptible) to selected antimicrobial agents were calculated by type of HAI and compared to historical data. Results.: Overall, 2,039 hospitals reported 1 or more HAIs; 1,749 (86%) were general acute care hospitals, and 1,143 (56%) had fewer than 200 beds. There were 69,475 HAIs and 81,139 pathogens reported. Eight pathogen groups accounted for about 80% of reported pathogens: Staphylococcus aureus (16%), Enterococcus spp. (14%), Escherichia coli (12%), coagulase-negative staphylococci (11%), Candida spp. (9%), Klebsiella pneumoniae (and Klebsiella oxytoca ; 8%), Pseudomonas aeruginosa (8%), and Enterobacter spp. (5%). The percentage of resistance was similar to that reported in the previous 2-year period, with a slight decrease in the percentage of S. aureus resistant to oxacillins (MRSA). Nearly 20% of pathogens reported from all HAIs were the following multidrug-resistant phenotypes: MRSA (8.5%); vancomycin-resistant Enterococcus (3%); extended-spectrum cephalosporin-resistant K. pneumoniae and K. oxytoca (2%), E. coli (2%), and Enterobacter spp. (2%); and carbapenem-resistant P. aeruginosa (2%), K. pneumoniae/oxytoca (<1%), E, coli (<1%), and Enterobacter spp. (<1%). Among facilities reporting HAIs with 1 of the above gram-negative bacteria, 20%-40% reported at least 1 with the resistant phenotype. Conclusion.: While the proportion of resistant isolates did not substantially change from that in the previous 2 years, multidrug-resistant gram-negative phenotypes were reported from a moderate proportion of facilities.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Magiorakos, A.-P., Srinivasan, A., Carey, R. B., Carmeli, Y., Falagas, M. E., Giske, C. G., Harbarth, S., Hindler, J. F., Kahlmeter, G., Olsson-Liljequist, B., et al. (2012) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2011.03570.x · Cited by 14,449
Self-citationHidron, A. I., Edwards, J. R., Patel, J., Horan, T. C., Sievert, D. M., Pollock, D. A., Fridkin, S. K., & National Healthcare Safety Network Team and Participating National Healthcare Safety Network Facilities (2008) · Infection Control & Hospital Epidemiology · doi:10.1086/591861 · Cited by 3,724
Self-citationBradford, P. A., Bratu, S., Urban, C., Visalli, M., Mariano, N., Landman, D., Rahal, J. J., Brooks, S., Cebular, S., & Quale, J. (2004) · Clinical Infectious Diseases · doi:10.1086/421495 · Cited by 485
Health Care–Associated Invasive MRSA Infections, 2005-2008
Kallen, A. J. (2010) · JAMA · doi:10.1001/jama.2010.1115 · Cited by 439
Self-citationLewis, J. S., Herrera, M., Wickes, B., Patterson, J. E., & Jorgensen, J. H. (2007) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00576-07 · Cited by 231
Landrum, M. L., Neumann, C., Cook, C., Chukwuma, U., Ellis, M. W., Hospenthal, D. R., & Murray, C. K. (2012) · JAMA · doi:10.1001/jama.2012.7139 · Cited by 228
Kallen, A. J., Hidrón, A., Patel, J. B., & Srinivasan, A. (2010) · Infection Control and Hospital Epidemiology · doi:10.1086/652152 · Cited by 158
Self-citationAnti-infective research and development—problems, challenges, and solutions
Bradley, J. S., Guidos, R., Baragona, S., Bartlett, J. G., Rubinstein, E., Zhanel, G. G., Tino, M. D., Pompliano, D. L., Tally, F., Tipirneni, P., et al. (2006) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(06)70689-2 · Cited by 99
Current Definitions of Central Line–Associated Bloodstream Infection Is the Emperor Wearing Clothes?
Sexton, D. J., Chen, L. F., & Anderson, D. J. (2010) · Infection Control and Hospital Epidemiology · doi:10.1086/657583 · Cited by 59
Cited by
Tong, S. Y. C., Davis, J. S., Eichenberger, E., Holland, T. L., & Fowler, V. G. (2015) · Clinical Microbiology Reviews · doi:10.1128/cmr.00134-14 · Cited by 5,192
Kalil, A. C., Metersky, M. L., Klompas, M., Muscedere, J., Sweeney, D. A., Palmer, L. B., Napolitano, L. M., O'Grady, N. P., Bartlett, J. G., Carratalà, J., et al. (2016) · Clinical Infectious Diseases · doi:10.1093/cid/ciw353 · Cited by 3,892
Hidron, A. I., Edwards, J. R., Patel, J., Horan, T. C., Sievert, D. M., Pollock, D. A., Fridkin, S. K., & National Healthcare Safety Network Team and Participating National Healthcare Safety Network Facilities (2008) · Infection Control & Hospital Epidemiology · doi:10.1086/591861 · Cited by 3,724
Self-citationAntimicrobial Resistance in ESKAPE Pathogens
De Oliveira, D. M. P., Forde, B. M., Kidd, T. J., Harris, P. N. A., Schembri, M. A., Beatson, S. A., Paterson, D. L., & Walker, M. J. (2020) · Clinical Microbiology Reviews · doi:10.1128/cmr.00181-19 · Cited by 2,078
Antibiotics and Bacterial Resistance in the 21st Century
Fair, R. J., & Tor, Y. (2014) · Perspectives in Medicinal Chemistry · doi:10.4137/pmc.s14459 · Cited by 1,955
Coagulase-Negative Staphylococci
Becker, K., Heilmann, C., & Peters, G. (2014) · Clinical Microbiology Reviews · doi:10.1128/cmr.00109-13 · Cited by 1,628
Weiner, L. M., Webb, A. K., Limbago, B., Dudeck, M. A., Patel, J., Kallen, A. J., Edwards, J. R., & Sievert, D. M. (2016) · Infection Control & Hospital Epidemiology · doi:10.1017/ice.2016.174 · Cited by 1,313
Self-citationHealth care-associated infections – an overview
Haque, M., Sartelli, M., McKimm, J., & Abu Bakar, M. B. (2018) · Infection and Drug Resistance · doi:10.2147/idr.s177247 · Cited by 1,200
Clinical and Pathophysiological Overview of Acinetobacter Infections: a Century of Challenges
Wong, D., Nielsen, T. B., Bonomo, R. A., Pantapalangkoor, P., Luna, B., & Spellberg, B. (2017) · Clinical Microbiology Reviews · doi:10.1128/cmr.00058-16 · Cited by 1,170
Antimicrobial therapeutic drug monitoring in critically ill adult patients: a Position Paper#
Abdul-Aziz, M. H., Alffenaar, J.-W. C., Bassetti, M., Bracht, H., Dimopoulos, G., Marriott, D., Neely, M. N., Paiva, J.-A., Pea, F., Sjovall, F., et al. (2020) · Intensive Care Medicine · doi:10.1007/s00134-020-06050-1 · Cited by 1,081
Uncovering the mechanisms of Acinetobacter baumannii virulence
Harding, C. M., Hennon, S. W., & Feldman, M. F. (2018) · Nature Reviews Microbiology · doi:10.1038/nrmicro.2017.148 · Cited by 1,026
Tacconelli, E., Cataldo, M. A., Dancer, S. J., De Angelis, G., Falcone, M., Frank, U., Kahlmeter, G., Pan, A., Petrosillo, N., Rodríguez-Baño, J., et al. (2014) · Clinical Microbiology and Infection · doi:10.1111/1469-0691.12427 · Cited by 864
Different drugs for bad bugs: antivirulence strategies in the age of antibiotic resistance
Dickey, S. W., Cheung, G. Y. C., & Otto, M. (2017) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2017.23 · Cited by 799
Targeted versus universal decolonization to prevent ICU infection
Huang, S. S., Septimus, E., Kleinman, K., Moody, J., Hickok, J., Avery, T. R., Lankiewicz, J., Gombosev, A., Terpstra, L., Hartford, F., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1207290 · Cited by 795
The Enterococcus: a Model of Adaptability to Its Environment
García-Solache, M., & Rice, L. B. (2019) · Clinical Microbiology Reviews · doi:10.1128/cmr.00058-18 · Cited by 754
Weiner-Lastinger, L. M., Abner, S., Edwards, J. R., Kallen, A. J., Karlsson, M., Magill, S. S., Pollock, D., See, I., Soe, M. M., Walters, M. S., et al. (2020) · Infection Control & Hospital Epidemiology · doi:10.1017/ice.2019.296 · Cited by 707
Self-citationDiabetes and risk of surgical site infection: a systematic review and meta-analysis
Martin, E. T., Kaye, K. S., Knott, C., Nguyen, H., Santarossa, M., Evans, R., Bertran, E., & Jaber, L. (2016) · Infection Control & Hospital Epidemiology · doi:10.1017/ice.2015.249 · Cited by 666
National Healthcare Safety Network (NHSN) report, data summary for 2012, Device-associated module
Dudeck, M. A., Weiner, L. M., Allen-Bridson, K., Malpiedi, P. J., Peterson, K. D., Pollock, D. A., Sievert, D. M., & Edwards, J. R. (2013) · American Journal of Infection Control · doi:10.1016/j.ajic.2013.09.002 · Cited by 658
Self-citationEpidemiology and risk factors for invasive candidiasis
Yapar, N. (2014) · Therapeutics and Clinical Risk Management · doi:10.2147/tcrm.s40160 · Cited by 610
Permeability Barrier of Gram-Negative Cell Envelopes and Approaches To Bypass It
Zgurskaya, H. I., López, C. A., & Gnanakaran, S. (2015) · ACS Infectious Diseases · doi:10.1021/acsinfecdis.5b00097 · Cited by 580
Antibiotic Modulation of Capsular Exopolysaccharide and Virulence in Acinetobacter baumannii
Geisinger, E., & Isberg, R. R. (2015) · PLOS Pathogens · doi:10.1371/journal.ppat.1004691 · Cited by 548
Crank, C., & O'Driscoll, T. (2015) · Infection and Drug Resistance · doi:10.2147/idr.s54125 · Cited by 505
The scope of the antimicrobial resistance challenge
Okeke, I. N., de Kraker, M. E. A., Van Boeckel, T. P., Kumar, C. K., Schmitt, H., Gales, A. C., Bertagnolio, S., Sharland, M., & Laxminarayan, R. (2024) · The Lancet · doi:10.1016/s0140-6736(24)00876-6 · Cited by 474
The Staphylococcal Biofilm: Adhesins, Regulation, and Host Response
Paharik, A. E., & Horswill, A. R. (2016) · Microbiology Spectrum · doi:10.1128/microbiolspec.vmbf-0022-2015 · Cited by 471
A review of the recent advances in antimicrobial coatings for urinary catheters
Singha, P., Locklin, J., & Handa, H. (2017) · Acta Biomaterialia · doi:10.1016/j.actbio.2016.11.070 · Cited by 448
(2016) · The Lancet Global Health · doi:10.1016/s2214-109x(16)30148-6 · Cited by 432
Antibiotic resistance: What is so special about multidrug-resistant Gram-negative bacteria?
Exner, M., Bhattacharya, S., Christiansen, B., Gebel, J., Goroncy‐Bermes, P., Hartemann, P., Heeg, P., Ilschner, C., Krämer, A., Larson, E., et al. (2017) · PubMed · doi:10.3205/dgkh000290 · Cited by 429
Colistin-Resistant Acinetobacter baumannii: Beyond Carbapenem Resistance
Qureshi, Z. A., Hittle, L. E., O'Hara, J. A., Rivera, J. I., Syed, A., Shields, R. K., Pasculle, A. W., Ernst, R. K., & Doi, Y. (2015) · Clinical Infectious Diseases · doi:10.1093/cid/civ048 · Cited by 395
Wagenlehner, F. M., Umeh, O., Steenbergen, J., Yuan, G., & Darouiche, R. O. (2015) · The Lancet · doi:10.1016/s0140-6736(14)62220-0 · Cited by 388
Antibiotic stewardship in the intensive care unit
Luyt, C.-E., Bréchot, N., Trouillet, J.-L., & Chastre, J. (2014) · Critical Care · doi:10.1186/s13054-014-0480-6 · Cited by 388
Infection Prevention and Control Guideline for Cystic Fibrosis: 2013 Update
Saiman, L., Siegel, J. D., LiPuma, J. J., Brown, R. F., Bryson, E. A., Chambers, M. J., Downer, V. S., Fliege, J., Hazle, L. A., Jain, M., et al. (2014) · Infection Control & Hospital Epidemiology · doi:10.1086/676882 · Cited by 387
Global Emergence and Dissemination of Enterococci as Nosocomial Pathogens: Attack of the Clones?
Guzman Prieto, A. M., van Schaik, W., Rogers, M. R. C., Coque, T. M., Baquero, F., Corander, J., & Willems, R. J. L. (2016) · Frontiers in Microbiology · doi:10.3389/fmicb.2016.00788 · Cited by 385
Infections Caused by Resistant Gram‐Negative Bacteria: Epidemiology and Management
Kaye, K. S., & Pogue, J. M. (2015) · Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy · doi:10.1002/phar.1636 · Cited by 383
Teillant, A., Gandra, S., Barter, D., Morgan, D. J., & Laxminarayan, R. (2015) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(15)00270-4 · Cited by 379
Tackling Threats and Future Problems of Multidrug-Resistant Bacteria
Medina, E., & Pieper, D. H. (2016) · Current Topics in Microbiology and Immunology · doi:10.1007/82_2016_492 · Cited by 356
Antimicrobial activity of photocatalysts: Fundamentals, mechanisms, kinetics and recent advances
Ganguly, P., Byrne, C., Breen, A., & Pillai, S. C. (2018) · Applied Catalysis B: Environmental · doi:10.1016/j.apcatb.2017.11.018 · Cited by 351
Zilberberg, M. D., Shorr, A. F., Micek, S. T., Vazquez-Guillamet, C., & Kollef, M. H. (2014) · Critical Care · doi:10.1186/preaccept-6556009101270526 · Cited by 340
Rosenthal, V. D., Al-Abdely, H. M., El-Kholy, A. A., AlKhawaja, S. A. A., Leblebicioglu, H., Mehta, Y., Rai, V., Hung, N. V., Kanj, S. S., Salama, M. F., et al. (2016) · American Journal of Infection Control · doi:10.1016/j.ajic.2016.08.007 · Cited by 335
Abdallah, M., Benoliel, C., Drider, D., Dhulster, P., & Chihib, N.-E. (2014) · Archives of Microbiology · doi:10.1007/s00203-014-0983-1 · Cited by 324
Perez, K. K., Olsen, R. J., Musick, W. L., Cernoch, P. L., Davis, J. R., Peterson, L. E., & Musser, J. M. (2014) · Journal of Infection · doi:10.1016/j.jinf.2014.05.005 · Cited by 321
Biomedical Applications of Recombinant Silk‐Based Materials
Aigner, T. B., DeSimone, E., & Scheibel, T. (2018) · Advanced Materials · doi:10.1002/adma.201704636 · Cited by 318
Acinetobacter baumannii: Evolution of Antimicrobial Resistance—Treatment Options
Murray, G., Peleg, A., & Doi, Y. (2015) · Seminars in Respiratory and Critical Care Medicine · doi:10.1055/s-0034-1398388 · Cited by 316
Candida sp. Infections in Patients with Diabetes Mellitus
Rodrigues, C., Rodrigues, M., & Henriques, M. (2019) · Journal of Clinical Medicine · doi:10.3390/jcm8010076 · Cited by 315
Cerceo, E., Deitelzweig, S. B., Sherman, B. M., & Amin, A. N. (2016) · Microbial Drug Resistance · doi:10.1089/mdr.2015.0220 · Cited by 313
Rosenthal, V. D., Maki, D. G., Mehta, Y., Leblebicioglu, H., Memish, Z. A., Al-Mousa, H. H., Balkhy, H., Hu, B., Alvarez-Moreno, C., Medeiros, E. A., et al. (2014) · American Journal of Infection Control · doi:10.1016/j.ajic.2014.05.029 · Cited by 310
Self-citationGlobal spread of three multidrug-resistant lineages of Staphylococcus epidermidis
Lee, J. Y. H., Monk, I. R., Gonçalves da Silva, A., Seemann, T., Chua, K. Y. L., Kearns, A., Hill, R., Woodford, N., Bartels, M. D., Strommenger, B., et al. (2018) · Nature Microbiology · doi:10.1038/s41564-018-0230-7 · Cited by 299
Antimicrobial blue light inactivation of pathogenic microbes: State of the art
Wang, Y., Wang, Y., Wang, Y., Murray, C. K., Hamblin, M. R., Hooper, D. C., & Dai, T. (2017) · Drug Resistance Updates · doi:10.1016/j.drup.2017.10.002 · Cited by 296
Epidemiology of antimicrobial resistance in bloodstream infections
Akova, M. (2016) · Virulence · doi:10.1080/21505594.2016.1159366 · Cited by 292
Estimating National Trends in Inpatient Antibiotic Use Among US Hospitals From 2006 to 2012
Baggs, J., Fridkin, S. K., Pollack, L. A., Srinivasan, A., & Jernigan, J. A. (2016) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2016.5651 · Cited by 268
Self-citationMicek, S. T., Wunderink, R. G., Kollef, M. H., Chen, C., Rello, J., Chastre, J., Antonelli, M., Welte, T., Clair, B., Ostermann, H., et al. (2015) · Critical Care · doi:10.1186/s13054-015-0926-5 · Cited by 267
An update on the management of urinary tract infections in the era of antimicrobial resistance
Bader, M. S., Loeb, M., & Brooks, A. A. (2017) · Postgraduate Medicine · doi:10.1080/00325481.2017.1246055 · Cited by 261
Chng, K. R., Li, C., Bertrand, D., Ng, A. H. Q., Kwah, J. S., Low, H. M., Tong, C., Natrajan, M., Zhang, M. H., Xu, L., et al. (2020) · Nature Medicine · doi:10.1038/s41591-020-0894-4 · Cited by 261
Satlin, M. J., Jenkins, S. G., & Walsh, T. J. (2014) · Clinical Infectious Diseases · doi:10.1093/cid/ciu052 · Cited by 255
Zonaro, E., Lampis, S., Turner, R. J., Qazi, S. J. S., & Vallini, G. (2015) · Frontiers in Microbiology · doi:10.3389/fmicb.2015.00584 · Cited by 252
Poolman, J. T., & Wacker, M. (2016) · Journal of Infectious Diseases · doi:10.1093/infdis/jiv429 · Cited by 246
(2021) · doi:10.3322/caac.21697 · Cited by 201
Thabit, A. K., Crandon, J. L., & Nicolau, D. P. (2015) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.2015.993381 · Cited by 160
The Empirical Combination of Vancomycin and a -Lactam for Staphylococcal Bacteremia
McConeghy, K. W., Bleasdale, S. C., & Rodvold, K. A. (2013) · Clinical Infectious Diseases · doi:10.1093/cid/cit560 · Cited by 90
Faron, M. L., Buchan, B. W., Coon, C., Liebregts, T., van Bree, A., Jansz, A. R., Soucy, G., Korver, J., & Ledeboer, N. A. (2016) · Journal of Clinical Microbiology · doi:10.1128/jcm.01040-16 · Cited by 63
Rat Indwelling Urinary Catheter Model of Candida albicans Biofilm Infection
Nett, J. E., Brooks, E. G., Cabezas-Olcoz, J., Sanchez, H., Zarnowski, R., Marchillo, K., & Andes, D. R. (2014) · Infection and Immunity · doi:10.1128/iai.02284-14 · Cited by 58
Wiederhold, N. P., Najvar, L. K., Fothergill, A. W., Bocanegra, R., Olivo, M., McCarthy, D. I., Kirkpatrick, W. R., Fukuda, Y., Mitsuyama, J., & Patterson, T. F. (2015) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.04228-14 · Cited by 36
Alp, S., Arikan‐Akdagli, S., Gulmez, D., Ascioglu, S., Uzun, O., & Akova, M. (2015) · Mycoses · doi:10.1111/myc.12349 · Cited by 32
Lone, S. A., Khan, S., & Ahmad, A. (2020) · Archives of Microbiology · doi:10.1007/s00203-019-01781-2 · Cited by 32
Stone, J., Bianco, A., Monro, J., Overybey, J. R., Cadet, J., Choi, K. H., Pena, J., Robles, B. N., Mella, M. T., Matthews, K. C., et al. (2020) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2020.05.021 · Cited by 18
Singh, N., Gulhane, R. D., Singh, A., Goel, M., Udelal, P. P., Sangwan, V., Sihag, M. K., Goel, G., Panwar, H., & Puniya, A. K. (2025) · Frontiers in Chemistry · doi:10.3389/fchem.2025.1425666 · Cited by 9
Metadata
- Authors
- Sievert, D. M., Ricks, P., Edwards, J. R., Schneider, A., Patel, J., Srinivasan, A., Kallen, A., Limbago, B., Fridkin, S., & National Healthcare Safety Network (NHSN) Team and Participating NHSN Facilities
- Venue
- Infection Control & Hospital Epidemiology
- Publisher
- Cambridge University Press (CUP)
- Published
- 2013-01
- Volume
- 34
- Issue
- 1
- Pages
- 1-14
- ISSN
- 0899-823X (ISSN-L)
- 1559-6834
- OpenAlex
- W4230543984
- Cited by
- 1,582
- References
- 9
- FWCI
- 48.61
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.